Subin Kim is a PhD candidate at MD Anderson Cancer Center, where they are utilizing multiplex CRISPR technology to uncover novel therapeutic vulnerabilities in cancer in Dr. Traver Hart's lab. Previously, Subin served as a research professional at Stanford University School of Medicine, leading CRISPR co-culture screenings to study immune evasion in breast and ovarian cancer. They also have experience as an organic chemistry teaching assistant at the University of California, Berkeley, and conducted undergraduate research focusing on neuroprotection in ALS. Subin is currently the Strategy Lead at Nucleate Houston, working to bridge biology, data, and strategy to enhance oncology impact.
This person is not in the org chart
This person is not in any teams
This person is not in any offices